Literature DB >> 32453137

A pain-induced tonic hypodopaminergic state augments phasic dopamine release in the nucleus accumbens.

Taylor A Gee1, Nathan C Weintraub1, Dong Lu2, Caroline E Phelps2, Edita Navratilova2, Michael L Heien1, Frank Porreca2.   

Abstract

Diseases and disorders such as Parkinson disease, schizophrenia, and chronic pain are characterized by altered mesolimbic dopaminergic neurotransmission. Dopamine release in the nucleus accumbens influences behavior through both tonic and phasic signaling. Tonic dopamine levels are hypothesized to inversely regulate phasic signals through dopamine D2 receptor feedback inhibition. We tested this hypothesis directly in the context of ongoing pain. Tonic and phasic dopamine signals were measured using fast-scan controlled-adsorption voltammetry and fast-scan cyclic voltammetry, respectively, in the nucleus accumbens shell of male rats with standardized levels of anesthesia. Application of capsaicin to the cornea produced a transient decrease in tonic dopamine levels. During the pain-induced hypodopaminergic state, electrically evoked phasic dopamine release was significantly increased when compared to baseline, evoked phasic release. A second application of capsaicin to the same eye had a lessened effect on tonic dopamine suggesting desensitization of TRPV1 channels in that eye. Capsaicin treatment in the alternate cornea, however, again produced coincident decreased dopaminergic tone and increased phasic dopamine release. These findings occurred independently of stimulus lateralization relative to the hemisphere of dopamine measurement. Our data show that (1) the mesolimbic dopamine circuit reliably encodes acute noxious stimuli; (2) ongoing pain produces decreases in dopaminergic tone; and (3) pain-induced decreases in tonic dopamine correspond to augmented evoked phasic dopamine release. Enhanced phasic dopamine neurotransmission resulting from salient stimuli may contribute to increased impulsivity and cognitive deficits often observed in conditions associated with decreased dopaminergic tone, including Parkinson disease and chronic pain.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32453137      PMCID: PMC7508893          DOI: 10.1097/j.pain.0000000000001925

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   7.926


  68 in total

Review 1.  The tonic/phasic model of dopamine system regulation: its relevance for understanding how stimulant abuse can alter basal ganglia function.

Authors:  A A Grace
Journal:  Drug Alcohol Depend       Date:  1995-02       Impact factor: 4.492

2.  Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain.

Authors:  Claudia Sagheddu; Sonia Aroni; Marta De Felice; Salvatore Lecca; Antonio Luchicchi; Miriam Melis; Anna Lisa Muntoni; Rosaria Romano; Enza Palazzo; Francesca Guida; Sabatino Maione; Marco Pistis
Journal:  Neuropharmacology       Date:  2015-06-22       Impact factor: 5.250

3.  Agonist- and Ca2+-dependent desensitization of TRPV1 channel targets the receptor to lysosomes for degradation.

Authors:  Lucía Sanz-Salvador; Amparo Andrés-Borderia; Antonio Ferrer-Montiel; Rosa Planells-Cases
Journal:  J Biol Chem       Date:  2012-04-06       Impact factor: 5.157

Review 4.  Clinical pain in schizophrenia: a systematic review.

Authors:  Gwenda Engels; Anneke L Francke; Berno van Meijel; Johanna G Douma; Heidi de Kam; Wubbien Wesselink; Wim Houtjes; Erik J A Scherder
Journal:  J Pain       Date:  2013-12-21       Impact factor: 5.820

5.  Executive function and decision-making in women with fibromyalgia.

Authors:  Antonio Verdejo-García; Francisca López-Torrecillas; Elena Pita Calandre; Antonia Delgado-Rodríguez; Antoine Bechara
Journal:  Arch Clin Neuropsychol       Date:  2009-03-11       Impact factor: 2.813

Review 6.  The dopamine hypothesis of schizophrenia: version III--the final common pathway.

Authors:  Oliver D Howes; Shitij Kapur
Journal:  Schizophr Bull       Date:  2009-03-26       Impact factor: 9.306

7.  Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats.

Authors:  Joseph F Cheer; Kate M Wassum; Michael L A V Heien; Paul E M Phillips; R Mark Wightman
Journal:  J Neurosci       Date:  2004-05-05       Impact factor: 6.167

8.  Signal valence in the nucleus accumbens to pain onset and offset.

Authors:  Lino Becerra; David Borsook
Journal:  Eur J Pain       Date:  2008-01-28       Impact factor: 3.931

Review 9.  Striatal direct and indirect pathways control decision-making behavior.

Authors:  Tom Macpherson; Makiko Morita; Takatoshi Hikida
Journal:  Front Psychol       Date:  2014-11-12

10.  Functionally Distinct Dopamine Signals in Nucleus Accumbens Core and Shell in the Freely Moving Rat.

Authors:  Jakob K Dreyer; Caitlin M Vander Weele; Vedran Lovic; Brandon J Aragona
Journal:  J Neurosci       Date:  2016-01-06       Impact factor: 6.167

View more
  4 in total

1.  Novel, User-Friendly Experimental and Analysis Strategies for Fast Voltammetry: Next Generation FSCAV with Artificial Neural Networks.

Authors:  Sergio Mena; Marco Visentin; Colby E Witt; Lauren E Honan; Nathan Robins; Parastoo Hashemi
Journal:  ACS Meas Sci Au       Date:  2022-04-06

2.  Dopamine receptor D2 regulates GLUA1-containing AMPA receptor trafficking and central sensitization through the PI3K signaling pathway in a male rat model of chronic migraine.

Authors:  Wei Zhang; Ming Lei; Qianwen Wen; Dunke Zhang; Guangcheng Qin; Jiying Zhou; Lixue Chen
Journal:  J Headache Pain       Date:  2022-08-10       Impact factor: 8.588

3.  Dysregulation of dopamine neurotransmission in the nucleus accumbens in immobilization-induced hypersensitivity.

Authors:  Yuki Kishikawa; Yukie Kawahara; Yoshinori N Ohnishi; Naoki Sotogaku; Tomoko Koeda; Hiroshi Kawahara; Akinori Nishi
Journal:  Front Pharmacol       Date:  2022-09-08       Impact factor: 5.988

4.  Pain-Related Abnormal Neuronal Synchronization of the Nucleus Accumbens in Parkinson's Disease.

Authors:  Kaoru Kinugawa; Tomoo Mano; Yuya Yamatani; Toshiteru Miyasaka; Hiroshi Kataoka; Kazuma Sugie
Journal:  Brain Sci       Date:  2022-01-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.